The study is being done with people who are taking their first anti-HIV drug regimen (including an Non-Nucleoside Reverse...
Study Objective: Compare longitudinal HIV-1 antibody responses among HIV-1 infected participants that either did or did not...
We will address our hypothesis using a case-control study design. We plan to leverage the existing biorepository of...
A5329 is a study for people who are infected with both HIV and the Hepatitis C virus (HCV) and have never taken Hepatitis C...
ACTG A5324 is a phase IV randomized, double-blinded, placebo-controlled study to assess the efficacy of adding Maraviroc (MVC)...
